Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID06527183

Fibromyalgia and Small Fiber Neuropathy: Which Prevalence and Relationship With Pain?

Led by Hospital Ambroise Paré Paris · Updated on 2025-09-10

150

Participants Needed

2

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the presence of small fiber neuropathy in patients with fibromyalgia compared to those with other types of chronic pain and healthy individuals. The study aims to better understand the role of small nerve fiber abnormalities in fibromyalgia symptoms and pain. This observational study will use structural and functional tests to explore the characteristics and impact of small fiber neuropathy in these groups. Participants will undergo skin punch biopsies to measure nerve fiber density and several functional tests including quantitative sensory testing, laser evoked potentials, Sudoscan, and confocal corneal microscopy. The study includes three groups: fibromyalgia patients, patients with other chronic pain types, and healthy controls matched by age and gender. These assessments will be done at the start and after six months to monitor changes. During the study, participants will be evaluated through clinical examinations, skin biopsies, and multiple sensory and nerve function tests. Researchers will measure the prevalence of small fiber neuropathy, correlate nerve fiber density with pain and quality of life, and assess the diagnostic value of various tests. The study will last at least six months and includes ongoing monitoring of symptoms and nerve function over time.

CONDITIONS

Brief Title

Fibromyalgia and Small Fiber Neuropathy

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years or older
  • Provided signed consent to participate
  • Affiliated with the French social security system
  • Able to be followed for the entire study duration
  • Able to read and understand French
  • Agree to the study principles and able to comply
  • Chronic pain lasting at least 6 months with moderate intensity (≥ 4/10)
  • Fibromyalgia diagnosed by FiRST questionnaire and WHO criteria, or chronic nociceptive or nociplastic pain without fibromyalgia
  • Untreated or stable analgesic treatment for at least 2 weeks prior to inclusion
  • Normal neurological examination at inclusion
Not Eligible

You will not qualify if you...

  • Involved in litigation or seeking compensation
  • Cancer diagnosis within the last 2 years
  • Known causes of small fiber neuropathy such as diabetes, systemic disease, hypothyroidism, alcohol use, kidney failure, or genetic disease
  • Clinical or EMG neuropathy
  • Peripheral or central nervous system disease with or without neuropathic pain
  • Uncontrolled chronic conditions like morbid obesity, sleep apnea, uncontrolled hypertension
  • Psychosis or previous suicide attempt
  • Drug or psychoactive substance abuse
  • Cognitive or psychological disorders preventing protocol compliance or understanding
  • Participation in another biomedical research study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Baseline and 6 months

Participants undergo diagnostic tests including skin punch biopsy, quantitative sensory testing, laser evoked potential recordings, Sudoscan, and confocal corneal microscopy to assess small fiber neuropathy and related abnormalities.

2 visits (in-person)

Long-term Monitoring

Duration - 6 months

Participants are observed over 6 months to monitor the evolution of abnormalities and symptoms related to small fiber neuropathy and fibromyalgia.

Visits coincide with diagnostic evaluation visits

Trial Site Locations

Total: 2 locations

1

Inserm U987

Boulogne-Billancourt, France, 92100

Actively Recruiting

2

Centre d'Evaluation et de Traitement de la douleur

Paris, France, 75014

Actively Recruiting

Loading map...

Research Team

N

Nadine ATTAL, MD PhD

D

Didier BOUHASSIRA, MD PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here